| Nome del prodotto | Acarbose |
|---|---|
| Numero CAS | 56180-94-0 |
| Formula molecolare | C25H43NO18 |
| Peso molecolare | 645.61 g/mol |
| Aspetto | Polvere cristallina di colore da bianco a bianco sporco |
| Analisi (HPLC) | ≥98.0% |
| Perdita per essiccazione | ≤0,51 TP3T |
| Residuo di combustione | ≤0,11 TP3T |
| Metalli pesanti | ≤10 ppm |
| Punto di fusione | ~165°C (decomposes) |
| Rotazione specifica | [α]D²⁵ = +165° to +175° (c=1, water) |
Hai bisogno di aiuto? Contatta il nostro team

Bay-g 5421, Glucobay, Precose, Prandase, Acarbose anhydrous, Acarbose EP, α-Glucosidase inhibitor.
Acarbose is the go-to alpha-glucosidase inhibitor for type 2 diabetes management, and it’s earned that spot by doing something most oral antidiabetics don’t: it works right in the gut, not in the bloodstream. By reversibly blocking the enzymes that break down complex carbs, it slows glucose absorption after meals—flattening those postprandial spikes that drive HbA1c up. For formulators, that means a drug that’s both effective and well-tolerated, with a mechanism that complements metformin and sulfonylureas nicely.
We supply acarbose as a high-purity crystalline powder, every batch meeting strict pharmacopoeial standards. Each shipment includes a full COA, and we pack from 100g R&D samples to multi-hundred-kilo drums for commercial production. Lead times are typically 7–10 days for stock items, and we ship worldwide with full documentation.